Cargando…
INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study
BACKGROUND: Glioblastoma multiforme (GBM) is the most frequent primary malignant brain tumor in adults. Despite multimodal therapies, almost all GBM recur within a narrow margin around the initial resected lesion. Thus, novel therapeutic intensification strategies must target both, the population of...
Autores principales: | Giordano, Frank A, Brehmer, Stefanie, Abo-Madyan, Yasser, Welzel, Grit, Sperk, Elena, Keller, Anke, Schneider, Frank, Clausen, Sven, Herskind, Carsten, Schmiedek, Peter, Wenz, Frederik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364103/ https://www.ncbi.nlm.nih.gov/pubmed/25535398 http://dx.doi.org/10.1186/1471-2407-14-992 |
Ejemplares similares
-
TARGIT-E(lderly)—Prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer
por: Neumaier, Christian, et al.
Publicado: (2012) -
Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases - a randomized phase III study
por: Bludau, Frederic, et al.
Publicado: (2019) -
Long-term changes in blood counts after intraoperative radiotherapy for breast cancer—single center experience and review of the literature
por: Wersal, Cornelia, et al.
Publicado: (2019) -
Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas
por: Sarria, Gustavo R., et al.
Publicado: (2020) -
Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity
por: Shelan, Mohamed, et al.
Publicado: (2013)